Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 128K 117K 107K 200K 13.57M 204K 1.4M 566K 7.16M 538K 527K 22.63M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.49M 18.8M 17.1M 32.06M 2.17B 32.7M 225M 90.52M 1.15B 86.13M 84.29M 3.62B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.84% | +0.44% | +23.23% | +53.08% | 253B | |
| +1.66% | +0.09% | +8.48% | +17.36% | 160B | |
| +0.76% | -1.12% | -18.99% | +58.30% | 151B | |
| +0.25% | -1.52% | -54.99% | -15.52% | 64.23B | |
| -0.43% | +3.53% | -11.20% | -9.65% | 54.11B | |
| +2.44% | +5.38% | +15.22% | +42.70% | 53.76B | |
| -0.39% | -3.02% | +3.85% | +56.23% | 49.71B | |
| +2.88% | +0.02% | +22.69% | +62.83% | 48.49B | |
| +4.52% | +0.94% | +36.85% | +81.56% | 44.17B | |
| Average | +1.52% | -0.76% | +2.79% | +38.54% | 97.69B | |
| Weighted average by Cap. | +1.49% | -0.75% | +4.50% | +40.10% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.54M 1.42M 1.29M 2.42M 164M 2.46M 16.92M 6.82M 86.41M 6.49M 6.35M 273M | 1.98M 1.77M 1.62M 1.47M 2.76M 187M 2.82M 19.35M 7.8M 98.83M 7.42M 7.26M 312M |
| Net income | -16.08M -14.35M -13.17M -11.98M -22.46M -1.52B -22.91M -157M -63.41M -803M -60.34M -59.05M -2.54B | -29.31M -26.17M -24.02M -21.85M -40.96M -2.78B -41.78M -287M -116M -1.46B -110M -108M -4.63B |
| Net Debt | 20.53M 18.33M 16.82M 15.3M 28.68M 1.94B 29.25M 201M 80.96M 1.03B 77.04M 75.39M 3.24B | 22.8M 20.36M 18.68M 17M 31.86M 2.16B 32.5M 223M 89.95M 1.14B 85.59M 83.76M 3.6B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
